Gene-silencing therapies may finally be able to reach hard-to-target organs like the brain and kidney by hitching a ride on the body’s own delivery vesicles, which naturally home to specific cell types and can deliver RNA drugs at far lower, safer doses.
ACCESS Health International
The promise…
Leave a Reply